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Abstract
Lower jaw deformity (LJD) is a skeletal anomaly affecting farmed triploid Atlantic salmon
(Salmo salar L.) which leads to considerable economic losses for industry and has animal
welfare implications. The present study employed transcriptome analysis in parallel with
real-time qPCR techniques to characterise for the first time the LJD condition in triploid
Atlantic salmon juveniles using two independent sample sets: experimentally-sourced
salmon (60 g) and commercially produced salmon (100 g). A total of eleven genes, some
detected/identified through the transcriptome analysis (fbn2, gal and gphb5) and others pre-
viously determined to be related to skeletal physiology (alp, bmp4, col1a1, col2a1, fgf23,
igf1, mmp13, ocn), were tested in the two independent sample sets. Gphb5, a recently dis-
covered hormone, was significantly (P < 0.05) down-regulated in LJD affected fish in both
sample sets, suggesting a possible hormonal involvement. In-situ hybridization detected
gphb5 expression in oral epithelium, teeth and skin of the lower jaw. Col2a1 showed the
same consistent significant (P < 0.05) down-regulation in LJD suggesting a possible carti-
laginous impairment as a distinctive feature of the condition. Significant (P < 0.05) differen-
tial expression of other genes found in either one or the other sample set highlighted the
possible effect of stage of development or condition progression on transcription and
showed that anomalous bone development, likely driven by cartilage impairment, is more
evident at larger fish sizes. The present study improved our understanding of LJD suggest-
ing that a cartilage impairment likely underlies the condition and col2a1 may be a marker. In
addition, the involvement of gphb5 urges further investigation of a hormonal role in LJD and
skeletal physiology in general.
Introduction
Lower jaw deformity (LJD) is a skeletal anomaly affecting the lower jaw of farmed Atlantic
salmon (Salmo salar L.). Specifically, LJD is a downward curvature of the lower jaw involving
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dentary and glossohyal bones [1, 2]. LJD has been frequently observed and identified in both
freshwater and seawater phases of production in all countries producing Atlantic salmon at/
with different prevalence between years and populations [3–9]. Although LJD can occur in
diploid populations at very low prevalence, LJD was linked to triploid Atlantic salmon in all
recent studies cited above. In Tasmania (Australia) LJD prevalence of up to 30% has been
reported in farmed triploid populations [7, 10]. Triploids are a valuable part of the annual har-
vest cycle as they do not undergo sexual maturation therefore can be harvested during the
reproductive seasons providing fresh product all year round [7]. As a consequence, LJD
affected triploid fish represent a considerable loss of production because they have lower
growth rates and cannot be sold whole due to their visual unattractiveness [5, 7, 11]. Further-
more, fish affected by skeletal anomalies usually require hand-grading which is an expensive
process and adds further cost [12, 13].
Although LJD is a frequently occurring skeletal anomaly in triploid Atlantic salmon its
causes have not yet been investigated in depth. Only recently, development of LJD has been
linked to dietary phosphorus (P) deficiency and a higher P requirement of triploid Atlantic
salmon [8]. Nevertheless, the mechanisms underlying the onset of LJD are not known and
could be multifactorial via a combination of genetic (triploidy and genetic background), nutri-
tional (mineral or vitamin deficiency) and environmental (accelerated growth, low dissolved
oxygen, elevated temperature and husbandry practices) factors [6–8, 14]. Although it seems to
occur mostly during the freshwater phase, onset of LJD can occur at any time in development
and prevalence and severity (i.e. worsening of the downward curvature) can increase over time
[3, 4, 7–9, 11, 14, 15].
The lower jaw in Atlantic salmon is a heterogeneous organ constituted of different tissues.
The bone of the lower jaw (i.e. dentary) is composed of compact bone directly ossifying around
the Meckel’s cartilage [1, 16–18]. An assessment screening the differential gene expression
between LJD and normal individuals, mostly focusing on cartilage and bone physiology, repre-
sents a basic approach to shed more light on the mechanisms underlying the condition.
Obtaining a significant number of individuals affected by LJD, both in controlled experimental
conditions and at commercial farm sites is difficult and labour-intensive. In this research, the
opportunity was presented to analyse a sufficient number of fish affected by LJD from inde-
pendent sample sets and at different developmental stages.
The aims of this study were to delineate for the first time through molecular techniques,
transcriptome analysis and real-time qPCR, differential gene expression in the jaw of fish
affected by LJD (compared to normal fish) in independent sample sets at different develop-
mental stages and to detect genes which correlate with, and may characterise LJD, allowing the
description of possible mechanisms underlying the condition. Furthermore, the specific gene
expression pattern observed was used to propose the tissue responsible for the development of
the condition. To support the analytical process, our findings are compared at a molecular
level with anomalous skeletal processes described in other vertebrates.
Results
Transcriptome analysis of the experimental sample set
De novo assembly of the transcriptome data gave a total of 62,373 contigs (including scaffolded
regions) with a minimum length of 500, a maximum of 14,769 and an average of 1,482 bases.
A total of 515 transcripts had at least 2 fold change between the LJD and Normal samples
(unadjusted P< 0.05). When restricting RPKM 1 in at least one sample and defining the
minimum as RPKM = 0.05, a total of 6,207 transcripts had at least 2 fold change between the
LJD and Normal samples (unadjusted P< 0.05), indicating that most of the DGE can be
Lower Jaw Deformity in Triploid Atlantic Salmon (Salmo salar L.)
PLOS ONE | DOI:10.1371/journal.pone.0168454 December 15, 2016 2 / 21
attributed to transcripts which do not express in one group while they do in the other. Since in
most cases these transcripts had very small RPKM values, we decided to focus on the 515
transcripts.
Out of the 515 transcripts, 452 were down-regulated and 63 were up-regulated in LJD. The
hierarchical clustering of differential gene expression showed that samples clustered tightly
together based on jaw trait (LJD/Normal; Fig 1B left), strengthening the validity of the differ-
ential gene expression analysis.
Fig 1. a) Atlantic salmon individuals displaying a normal jaw (Normal) on the left and a lower jaw deformity (LJD) on the right (scale bar = 1 cm). Dashed lines
highlight normal and anomalous profiles. b) Hierarchical clustering showing differentially expressed transcripts between Normal vs. LJD grouped samples
retrieved after a pairwise comparison. Each row corresponds to one sample tested and each column corresponds to a single differentially expressed
transcript. On the hierarchical tree at the left side of the map, the upper half (orange) indicates the Normal samples and the lower half (green) indicates the
LJD samples. Relative gene expression is indicated by colour: red is higher-level expression relative to the sample mean, blue is relatively lower-level
expression, grey is no-change. The 452 genes on the left were up-regulated in LJD samples relative to the Normal samples. The 63 genes on the right were
down-regulated in LJD samples relative to the Normal samples.
doi:10.1371/journal.pone.0168454.g001
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Following BLASTP selection according to E-value (for matches and hits) and RPKM-based
filter (as described in the materials and methods section), two tables were produced: one con-
sisting of 6 transcripts down-regulated in LJD samples (Table 1) and another consisting of 27
transcripts up-regulated in LJD samples (Table 2) ordered by E-value of the best hit (lowest to
highest) (tables are shown in the following paragraphs).
Down-regulated transcripts
Among the 63 transcripts of this subset, 18 could be reliably annotated via NCBI database with
E-value 1.00E-40. Of the 18 transcripts, six had a Sum of RPKM 5 across all four pooled
samples (Table 1). Transcript 59181, which corresponded to glycoprotein hormone beta 5
(gphb5) had a much higher fold change (-4.3) between the groups compared to other tran-
scripts. For five out of the above six transcripts, the best hit resulted in an unannotated product
described for Oncorhynchus mykiss (rainbow trout), a closely-related Salmonid species. The
actual hit for these transcripts resulted in products described in other Teleost species (Table 1).
Transcript 30200, which corresponded to aggrecan isoform 1 (acan1) and that was annotated
as aggrecan, had a best hit with a named product in the Salmonid Oncorhynchus keta (chum
salmon) (Table 1).
Up-regulated transcripts
Among the 452 transcripts of this subset, 176 could be reliably annotated via NCBI database
with E-value 1.00E-40. Of the 176 transcripts, 27 had a Sum of RPKM 5 (Table 2). Tran-
script 40854 was annotated as Four and a half LIM domains protein 2, transcript 2193 corre-
sponded to galactose-specific lectin (gal) and transcript 45908 was annotated as major
histocompatibility complex (MHC) class I antigen. These transcripts had a much higher fold
change (3.2, 3.5 and 4.6, respectively) between the groups, as compared with other transcripts.
For 15 out of the 27 transcripts, the best hit resulted in an unannotated product described for
the species O. mykiss. The actual hit for these transcripts resulted in products described in
other Teleost species (Table 2). Seven of the remaining 12 transcripts had best hits with named
products described for S. salar, and the last five with other Teleost species.
Real-time qPCR validation
The differential expression observed after the transcriptome analysis was confirmed for three
out of five transcripts. In particular, fibrillin 2 (fbn2) and gal were significantly (P< 0.05)
up-regulated in LJD affected fish while gphb5 was significantly (P< 0.05) down-regulated
in LJD affected fish (Fig 2). The differential expression of both acan1 and acan2, that were
Table 1. The six transcripts found down-regulated in LJD selected according to Sum of RPKM 5 across all 4 pooled samples ordered by E-value
of the best hit (lowest to highest).
Transcript Accession Best
Hit
E-value Best
hit
Accession Actual
Hit
Predicted product [species] E-value Actual
Hit
30200 BAJ61837 0.00 BAJ61837 aggrecan [Oncorhynchus keta] 0.00
8151 CDQ60370 0.00 BAJ61837 aggrecan [Oncorhynchus keta] 0.00
15298 CDQ84852 1.61E-137 XP_005945737 cytosolic phospholipase A2 gamma-like isoform X2
[Haplochromis burtoni]
1.24E-89
59181 CDQ81732 7.53E-96 XP_005455982 glycoprotein hormone beta-5-like [Oreochromis niloticus] 2.20E-72
662 CDQ80483 5.85E-86 XP_007243147 protein FAM111A-like [Astyanax mexicanus] 6.29E-75
26682 CDQ61726 5.09E-82 XP_007242859 mannose-specific lectin-like [Astyanax mexicanus] 1.23E-62
doi:10.1371/journal.pone.0168454.t001
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significantly down-regulated in LJD affected fish according to the transcriptome analysis, was
not confirmed by real-time qPCR assays (Fig 2).
Real-time qPCR of different developmental stages
Testing all the eleven transcripts available after initial selection and following transcriptome
analysis in both the experimental and the industrial sample set, only col2a1 and gphb5 showed
the same regulation pattern in both independent sample sets (Fig 3). In particular, col2a1 and
gphb5 were significantly (P< 0.05) down-regulated in fish with LJD compared to Normal fish
in the two independent sample sets (Fig 3). Other transcripts were found to be differentially
expressed between traits in one sample set only. In particular, fbn2 and gal were significantly
(P< 0.05) up-regulated in LJD in the experimental sample set only while alp, bmp4, col1a1,
igf1 and mmp13 were significantly (P< 0.05) down-regulated in LJD in the industrial sample
Table 2. The 27 transcripts found up-regulated in LJD selected according to Sum of RPKM 5 across all 4 pooled samples ordered by E-value of
the best hit (lowest to highest).
Transcript Accession Best
Hit
E-value Best
Hit
Accession Actual
Hit
Predicted product [species] E-value Actual
Hit
3859 CDQ85625 0.00 XP_006641632 IgGFc-binding protein-like [Lepisosteus oculatus] 5.60E-152
718 CDQ93202 0.00 XP_006641633 IgGFc-binding protein-like [Lepisosteus oculatus] 0.00
407 CDQ85625 0.00 XP_006641632 IgGFc-binding protein-like [Lepisosteus oculatus] 1.21E-151
5789 XP_005450984 0.00 XP_005450984 filamin-C-like isoform X3 [Oreochromis niloticus] 0.00
1330 CDQ86144 0.00 XP_008284200 xin actin-binding repeat-containing protein 1-like [Stegastes
partitus]
0.00
10204 XP_007252649 0.00 XP_007252649 collagen alpha-2(VI) chain-like [Astyanax mexicanus] 0.00
894 XP_006808726 0.00 XP_006808726 von Willebrand factor A domain-containing protein 7-like
[Neolamprologus brichardi]
0.00
40854 ACI68280 0.00 ACI68280 Four and a half LIM domains protein 2 [Salmo salar] 0.00
26217 ADD59862 0.00 ADD59862 immunoglobulin delta heavy chain constant region [Salmo salar] 0.00
31731 CDQ69338 0.00 XP_005163674 amylo-1, 6-glucosidase, 4-alpha-glucanotransferase isoform X1
[Danio rerio]
2.68E-128
7575 CDQ73728 4.69E-171 XP_008279287 pecanex-like protein 3 [Stegastes partitus] 5.79E-171
22520 CDQ71312 7.88E-158 XP_008293195 eukaryotic translation initiation factor 2-alpha kinase 4
[Stegastes partitus]
6.99E-120
12561 CDQ83306 3.64E-156 XP_006641633 IgGFc-binding protein-like [Lepisosteus oculatus] 1.42E-113
41692 CDQ61095 7.87E-156 XP_003966210 serum amyloid P-component-like [Takifugu rubripes] 2.85E-81
5264 ACI68585 2.30E-154 ACI68585 Heat shock protein 30 [Salmo salar] 2.30E-154
15329 NP_001118064 2.22E-135 NP_001118064 heat shock protein, alpha-crystallin-related, 1 [Oncorhynchus
mykiss]
2.22E-135
44416 CDQ81901 3.22E-125 XP_007243338 protein NLRC3-like [Astyanax mexicanus] 1.85E-70
15155 CDQ66610 7.50E-124 XP_008292526 protein NLRC3-like [Stegastes partitus] 9.50E-121
27480 CDQ68760 3.73E-113 XP_008278793 sortilin-related receptor [Stegastes partitus] 1.33E-84
2193 CDQ61022 2.60E-108 ACO13356 Galactose-specific lectin [Esox lucius] 5.21E-09
35957 XP_007258003 3.18E-100 XP_007258003 ryanodine receptor 3-like [Astyanax mexicanus] 3.18E-100
6273 CDQ74429 1.20E-84 XP_008303180 fibrillin-2-like, partial [Stegastes partitus] 1.35E-82
1876 NP_001117045 2.06E-83 NP_001117045 cathelicidin antimicrobial peptide precursor [Salmo salar] 2.06E-83
10290 NP_001134766 3.32E-61 NP_001134766 Heat shock protein beta-7 [Salmo salar] 3.32E-61
25466 NP_001134309 3.03E-59 NP_001134309 Natterin-like protein [Salmo salar] 3.03E-59
34091 CDQ58999 2.04E-56 XP_003968600 serine/threonine-protein kinase Nek8-like [Takifugu rubripes] 3.05E-47
45908 ACY30362 6.08E-48 ACY30362 MHC class I antigen [Salmo salar] 6.08E-48
doi:10.1371/journal.pone.0168454.t002
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set only (Fig 3). Fgf23and ocn, showed no differential expression between traits in both sample
sets.
Real-time qPCR for fish reared at different temperatures (14 vs 18˚C)
Among the transcripts tested for the effect of rearing temperature only col2a1 showed to be dif-
ferentially expressed. In particular, col2a1 was significantly (P< 0.05) down-regulated in LJD
within both temperature treatments and significantly (P< 0.05) up-regulated in both traits in
the elevated treatment (18˚C) compared to the standard treatment (14˚C) (Fig 4).
GPHB5 In-Situ Hybridization
In-situ hybridization analysis showed the expression of gphb5 in both traits (Normal and LJD)
to be mostly in the skin and more evident in the oral epithelium and at the tip of the lower jaw
(Fig 5). Furthermore, gphb5 was also expressed around the teeth, in particular in the outer den-
tal epithelium and around the dental papilla (Fig 5). Given the general low expression of the
gene a quantitative differential expression between Normal and LJD was not observed.
Fig 2. Relative expression (2-ΔΔCT, mean ± SEM) of selected transcripts (abbreviations described in the
text) found to be differentially expressed in two different categories (Normal and affected by lower jaw
deformity, LJD) after transcriptome analysis of triploid Atlantic salmon Salmo salar pre-smolts from the
experimental sample set (n = 6 per jaw trait). For each transcript, expression level means were compared
between different categories. Within each transcript, means significantly different from one another are indicated by
different letters (P < 0.05).
doi:10.1371/journal.pone.0168454.g002
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Discussion
In the present study, among the eleven genes tested in individuals displaying a normal lower
jaw or a LJD, only col2a1 and gphb5 showed the same consistent pattern of differential expres-
sion, being down-regulated in LJD affected fish in both independent sample sets. This result
implies that, in contrast to other genes found differentially expressed between traits either in
one sample set or in another, col2a1 and gphb5 are reliable indicators of the mechanisms
underlying LJD.
Col2a1 is an exclusive marker of cartilage and is responsible for the expression of type II
collagen, a basic protein for skeletogenesis in vertebrates [19–22]. In the present study, down-
regulation of col2a1 in LJD affected fish may thus indicate a compromised development of the
Meckel’s cartilage through loss of structural integrity and incorrect growth trajectory (pointing
downward) of the deriving or integrally-linked bone structure, the dentary bone (main lower
Fig 3. a) Relative expression (2-ΔΔCT, log-transformed mean + SEM) of the eleven transcripts tested in triploid Atlantic salmon Salmo salar individuals
belonging to two independent sample sets, ‘experimental’ (exp. 60 g) on the left and ‘industrial’ (ind. 100 g) on the right, and displaying a normal lower jaw
(Normal) or a lower jaw deformity (LJD) (n = 6 per jaw trait). Significantly different (P < 0.05) relative expression between traits is indicated by an asterisk. b) A
graphic summary of the previous graphs to show significantly different regulation (UP—red, DOWN—blue, NO—grey) and corresponding approximate fold
change (significant in bold) in LJD individuals only relative to Normal from the two independent sample sets. Columns of col2a1 and gphb5 have thicker
borders to highlight consistent differential expression between independent sample sets.
doi:10.1371/journal.pone.0168454.g003
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jaw bone). Type II collagen is produced by chondrocytes and represents the most abundant
protein in the cartilage extracellular matrix and is crucial for cartilage conformation and resis-
tance [19, 22–24]. In Atlantic salmon, Meckel’s cartilage does not ossify and plays a crucial
role in physically supporting the dentary, extending internally almost for its entire length [16–
18]. Considering the consistency of down-regulation of col2a1 in LJD-affected fish between
independent sample sets from different developmental stages (60 vs 100 g), this finding sug-
gests a cartilaginous impairment as a possible distinctive feature of the trait.
Defects in type II collagen have frequently been associated with the occurrence of impair-
ments in cartilage and as a consequence bone development in humans and mice [25–36]. In
support of our results, disruption of cartilage growth and development in LJD has been
reported by previous studies. X-ray analysis showed a diminution of the Meckel’s cartilage in
LJD-affected fish [2] and histological examination of LJD-affected Meckel’s cartilage showed
different left to right thickness, implying an impaired development [1]. Likewise, the lower jaw
of LJD-affected fish presented an incorrect assemblage and a smaller number of collagen fibres,
adding to the evidence that the anomaly may be due to an impairment in the jaw cartilage
Fig 4. Relative expression (2-ΔΔCT, mean ± SEM) of col2a1 in Normal and lower jaw deformity (LJD) affected
triploid Atlantic salmon Salmo salar (n = 6 per jaw trait) from the experimental sample set at standard (14˚C)
and elevated (18˚C) temperature. Means significantly different from one another are indicated by different letters
(P < 0.05).
doi:10.1371/journal.pone.0168454.g004
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development [37]. The studies mentioned above, analysed later stages of fish development
compared to the current study, supporting our theory that cartilaginous impairment is a dis-
tinctive feature of LJD at any stage.
Fig 5. Top panel: a) a transverse H&E stained section of the lower jaw of a triploid Atlantic salmon (~60 g) affected by lower jaw deformity
(LJD). Image series was tiled and black background was added using Photoshop. White arrows indicate the main anatomical features. In the
top right corner the drawing illustrates the location and position of the sections obtained. Bottom panels: in-situ hybridization stained sections
of a LJD affected jaw (region magnified from the corresponding H&E staining image is outlined in yellow at the top panel). b) Bottom left panel
shows the negative control where gphb5 sense probe was used while in c) the bottom right the tissue was hybridizing with the gphb5 anti-
sense probe. In the latter, the signal is detectable (purple stain) in the oral epithelium, around the teeth and in the skin at the tip of the jaw.
doi:10.1371/journal.pone.0168454.g005
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In the present study, the effect of water temperature on the up-regulation of col2a1 in both
jaw traits may be explained by an enhanced sensitivity of chondrocytes to higher temperatures
(i.e. change in shape of chondrocytes) as shown for vertebral deformities in Atlantic salmon
exposed to high water temperature [38]. In light of the above, prolonged exposure to high
water temperature, in particular for Atlantic salmon above 14–15˚C, may lead to a possible
exacerbation of cartilage impairment and likely increased LJD severity in both originally nor-
mal and LJD affected fish, but with likely greater impact on the latter.
The consistent down-regulation of gphb5 in LJD affected fish in both independent sample
sets, as well as its localization through in-situ hybridization in this study, provides further
insight into the onset of the condition, pointing towards a possible hormonal involvement.
Gphb5 is an evolutionarily well conserved glycoprotein hormone described for the first time in
humans in 2002 [39]. Expression of gphb5 occurs in several species in the pituitary, implying a
role in hypothalamus-pituitary peripheral tissue (HPT) axis [39, 40]. Gphb5 is known to acti-
vate the thyroid-stimulating hormone (TSH) receptors in cells of thyroid and it was named
thyrostimulin due to its ability to stimulate thyrotropin receptors [40]. Nevertheless, the pri-
mary role of the hormone is still unknown [41]. Gphb5 seems to have a paracrine rather than
an endocrine function, implying that it can be expressed locally and induce changes in nearby
cells [40, 41]. In the present study, the expression of gphb5 in the skin cells is in accordance to
that found in humans [42]. Furthermore, it has been recently shown that gphb5 plays a para-
crine role in skeletal development and bone formation [41]. In light of the above, our results
may suggest that gphb5 is expressed in the skin of the lower jaw and induce changes in cartilage
or bone cells located at short distance. Furthermore, considering the aforementioned relation
gphb5-thyroid, gphb5 down-regulation and consequent lower expression in LJD-affected indi-
viduals may indicate an underactive thyroid. Underactive thyroid is generally linked with
impairments in chondrocyte differentiation and linear growth as well as bone formation and
mineralization [41]. Since, as suggested by our results, LJD could be the result of a cartilagi-
nous impairment with resulting deleterious effects on bone development, the findings
reported above support and reinforce our theory that gphb5 is likely involved in mechanisms
underlying LJD and, although not expressed specifically in cartilage or bone in the present
study (mostly in oral epithelium, teeth and skin), gphb5 may act through paracrine pathways.
The literature for this relatively novel gene is limited and further investigations are needed to
verify its role in skeletal development and HPT [40–42]. Nevertheless, we suggest that gphb5
could be at least an indicator of a wider process behind the LJD condition in Atlantic salmon.
In support of a possible hormonal involvement in the condition, LJD has been recently
linked to dietary phosphorus (P) deficiency during early stages of development in Atlantic
salmon and different dietary P physiological requirements of triploids compared to diploids
[8]. As bone in particular and the skeleton in general have a key role in endocrine regulation of
minerals and nutrients [43], the onset of LJD could be either the result of a pre-existing
impairment in the hormonal pathways of phosphate regulation, possibly involving gphb5 as a
thyrostimulin, or that different physiological P requirements, especially in triploids, and die-
tary P deficiency may trigger or facilitate LJD onset with the effect displayed in the differential
expression of particular genes involved in phosphate hormonal control, with a possible role for
gphb5 as a thyrostimulin. In the present study, fgf23was not differentially expressed between
traits in both/either sample sets. This suggests that while there was no differential expression
of this important P homeostasis regulator at the fish development stages considered, an
impairment in P homeostasis may have occurred earlier, or may occur later, in the progression
of LJD. Alternatively, the impairment in P homeostasis linked to LJD in Atlantic salmon may
occur through a different molecular pathway, not involving fgf23.
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The predominant occurrence of LJD in triploids suggests that LJD it is likely to be associ-
ated with a disruption in timing/localization/function of gene expression, causing a temporal
imbalance of the orchestrated function at the transcription or translation machinery required
during embryonal development in order to generate complex traits. Nevertheless, the physio-
logical differences resulting from triploidy (e.g. fewer and bigger cells and dietary P require-
ments) are likely interrelated in LJD occurrence [5, 8]. Triploid induction in Atlantic salmon
is performed by pressure shocking eggs 30 min after fertilisation, during meiosis II [5, 44]. The
shock suppresses cell division and prevents the extrusion of a polar body, resulting in cells hav-
ing three sets of chromosomes instead of two [45]. Slight variations to pressure shock timing
and temperature may confer developmental variability between individuals and an uneven tri-
ploidization per egg batch. This could result in either a lower triploidy induction rate [45] or
potentially lead to imbalanced pathways where localised high levels of reactive oxygen species
(ROS) occur and these then cause DNA breaks, as similar stresses (e.g. sonication) have been
known to induce DNA breaks (http://cshprotocols.cshlp.org/content/2006/4/pdb.prot4538.
short). Following the findings of the present study, col2a1 and gphb5 may be tested as early
markers during embryonic development, in particular when Meckel’s cartilage differentiation
takes place, to detect potential differential expression between triploids from the same batch
and as a consequence to identify possible candidates that will develop LJD in future. In a recent
publication, single-nucleotide polymorphism (SNP) in col2a1 has been associated with man-
dibular prognathism, a lower jaw skeletal anomaly in humans [46]. Similar investigation
should be undertaken for the role of col2a1 in LJD in Atlantic salmon.
In the present study, additional genes important for skeletal physiology had different regu-
lation patterns between independent sample sets (i.e. differential expression in one but not in
the other sample set). Considering that the two sample sets included fish at different develop-
mental stages, our results suggest that fish age and/or consequent progression of the condition
may influence the expression of some genes relative to others. For instance, up-regulation of
both gal and fbn2 in LJD was detected only in the experimental sample set (the earlier develop-
mental stage), which may be the result of a particular process occurring at that stage (due to
development or condition). The process could be remodelling of the LJD affected jaw as a con-
sequence of incorrect growth, likely driven by impaired Meckel’s cartilage development, or
containment of the compromised structural integrity. In fact, members of the family of both
galectins and fibrillins have been shown to be involved in cartilage and bone formation and
development [47–54]. In particular, members of the galectins have been linked to diseases
heavily affecting cartilage (i.e. rheumatoid arthritis and osteoarthritis) [55–57] and have a role
in osteoblast differentiation, bone remodelling and osteoclastogenesis [49, 56, 58]. On the
other hand, fibrillins play a crucial role in maintaining the integrity of connective tissues, cor-
rect formation and remodelling of extracellular matrix and bone structural development with
effects on morphology and mechanical properties [53, 59].
In the industrial sample set, the LJD fish showed down-regulation of genes important for
skeletal physiology, which may support the hypothesis of the progression of the LJD condition
proposed above. Our results support a scenario where cartilage impairment leads to bone
development impairment that becomes more evident at later stages. For instance, down-regu-
lation of igf1 in LJD may indicate impaired growth/development of cartilage and bone as well
as poor mineralisation. Igf1 is known to modulate skeletal development and in particular bone
growth, resorption and mineralisation controlling proliferation and differentiation of chon-
drocytes, osteoblasts, osteocytes and osteoclasts [60–62]. Furthermore, given the possible inter-
dependency of igf1 and parathyroid hormone (PTH) for skeletal development [60, 63, 64] it
remains unclear whether or not igf1down-regulation later in development and consistent
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down-regulation of gphb5 in LJD in the present study may be part of the same cascade of
impairment in bone hormonal control.
Bmp4 down-regulation in LJD supports our hypothesis concerning the influence of devel-
opmental stage and/or condition progression on gene expression proposed above. Bone mor-
phogenetic proteins (BMPs), which are multi-functional growth factors of the transforming
growth factor b (TGFb) superfamily, play a fundamental role for cartilage and bone develop-
ment and their normal functioning is required to avoid skeletal defects or malformations [65,
66]. In particular, bmp4 has been repeatedly associated with mandibular or maxillofacial devel-
opment and shaping in fish, birds and mammals [67–70], and has been linked before to oral
malformations in birds [68, 71] and mammals [72], supporting and highlighting the possible
significance of this gene in the LJD condition.
Finally, the remaining genes down-regulated in LJD-affected fish, alp, col1a1 and mmp13,
probably indicate that the bone is not growing/developing correctly as a consequence of carti-
laginous impairment. In fact, all of these are well-known and important skeletal structural
genes: col1a1 encodes type I collagen, the main component of bone. Alp and mmp13 are
responsible for bone formation and mineralisation and cartilage and bone resorption, respec-
tively [73–79]. In Atlantic salmon, all these genes have been already shown to be differential
expressed in poorly mineralised and deformed vertebrae relative to normal vertebrae [8, 80,
81]. The current study suggests their involvement in the development of a skeletal anomaly
affecting the lower jaw in Atlantic salmon.
In conclusion, although the causes of LJD are still unknown, we have made the first contri-
bution, to our knowledge, to the understanding of the molecular mechanisms underlying the
condition. We propose col2a1 and gphb5 as reliable candidates for detection of the condition
due to their consistent down-regulation in LJD in two independent sample sets from two
developmental stages. The down-regulation of col2a1 here may indicate that LJD in Atlantic
salmon is attributable to impaired development and structural defects of Meckel’s cartilage. In
addition, we suggest that down-regulation and localization of gphb5 infers a possible hormonal
involvement in LJD. Although further investigation of the role of this hormone in LJD is
needed, we have enhanced our understanding of a relatively novel hormone and showed for
the first time that gphb5 may be part of a mechanism behind a skeletal anomaly. Differential
expression of other genes important for skeletal physiology in either one or the other sample
set suggests that developmental stage or progression of the LJD condition could influence their
transcription. Further molecular investigation of the marker candidates proposed in the cur-
rent study is warranted. It is also recommended to carry out future annotation and analysis of
paralogues using as reference the Atlantic salmon genome which has been recently made pub-
licly available [82]. Finally, P homeostasis, skeletal hormonal control and mineralisation/struc-
tural characterisation of LJD in triploid Atlantic salmon require elucidation.
Materials and Methods
Sample background, selection and tissue source
Two independent sample sets of all-female triploid Atlantic salmon (Salmo salar) individuals
were used in this study and both were provided by Petuna Seafoods hatchery in Cressy, Tas-
mania. All-female individuals were produced and triploidy was achieved as previously
described [10, 44]. Briefly, shock to induce triploidy occurred 30 min after fertilisation when
all-female eggs were subjected to a pressure at 9500 psi (655 Bar) for 4 min in water at 10˚C,
followed by 1 min for pressure release. Efficiency of the triploid induction was assessed by
measuring erythrocyte nuclear length [83] and confirmed as 100% successful. The first sample
set (defined “experimental” from now on) was collected at the end of the experiment described
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in [9]. Briefly, the individuals from the experimental sample set were triploized at hatchery site
but reared from incubation up to the sampling event in experimental facilities. Individuals
weighing approximately 60 g were sampled in March 2014 following exposure to a standard
temperature treatment (14˚C) for two months (additional samples were also collected from
individuals exposed to an elevated temperature treatment of 18˚C for two months for addi-
tional molecular investigations). The second sample set (defined “industrial” from now on)
was reared at a hatchery site and collected in November 2015. Fish sampled weighed approxi-
mately 100 g and were subjected to different conditions compared to the experimental sample
set (i.e. incubation and rearing temperature) and were derived from different broodstock. For
each sample set, fish were euthanized by anaesthetic overdose (AQUI-S: 50 mg L-1) and the
lower jaws of fish displaying LJD (LJD n = 6 per sample set) (Fig 1A) and of fish displaying a
phenotypically normal jaw (Normal n = 6 per sample set) (Fig 1A) were dissected and placed
in RNA preservation reagent (4 M ammonium sulphate, 25 mM sodium citrate, 10 mM
EDTA; pH 5.2) to preserve RNA integrity. The samples were held at 4˚C overnight and stored
at– 20˚C for a maximum of two months before processing for molecular analysis. For histolog-
ical analysis, the lower jaws of individuals from the experimental sample set displaying LJD
(n = 3) and phenotypically normal jaw (n = 3) were dissected and placed in Bouin’s solution
overnight and then preserved in 70% ethanol for a maximum of four months before the analy-
sis. All procedures were carried out with the approval of the University of Tasmania Animal
Ethics Committee (approval number A0013044).
RNA extraction and preparation for next generation sequencing
The lower jaw samples from the sample sets described above were carefully dissected, remov-
ing excess tissues in order to leave dentary bone and a thin layer of the surrounding tissues.
Samples were then homogenized using a LabGEN 7 Series Homogenizer (Cole Parmer, Ver-
non Hills, IL, USA) in vials containing RNAzol1 RT (Molecular Research Centre Inc., Cin-
cinnati, OH, USA) for the isolation of total RNA, following manufacturer’s instructions. The
isolated RNA was tested for quality and quantity using a NanoDrop 2000 spectrophotometer
(Thermo Scientific, NanoDrop Products, Wilmington, DE, USA). For next generation
sequencing, fish from the experimental sample set affected by LJD (n = 6) and phenotypically
normal (Normal) (n = 6) were used. Equal amounts of RNA from three individuals from the
same category were mixed to generate a total of four pooled samples representing two repli-
cates of LJD and two replicates of Normal. The Agilent 2100 bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA, USA) was used to validate quantity and quality of RNA. All samples had
RIN (RNA Integrity Number) values higher than 7.
Next generation sequencing and data handling
Samples were prepared for sequencing by the Australian Genome Research Facility (AGRF,
Melbourne, Australia) according to the manufacturer’s instructions (Illumina, San Diego, CA,
USA). Briefly, poly (A) mRNA was isolated using oligo (dT) beads and the addition of frag-
mentation buffer for shearing mRNA into short fragments (200–700 nt) prevented priming
bias during the synthesis of cDNA using random hexamer-primers. The short fragments were
further purified using QIAquick PCR purification kit (Qiagen, Hilden, Germany) and resolved
with EB buffer for ligation with Illumina Paired-end adapters. This was followed by size
selection (~200 bp), PCR amplification and Illumina sequencing using an Illumina Genome
Analyzer (HighSeq 2000, Illumina, San Diego, CA, USA) performing 100 bp–paired end
sequencing. The sequence reads were stored as FASTQ files. Overall, at least 4 Gb of cleaned
data (at least 50 million reads) was generated for each of the four samples sequenced. Prior to
Lower Jaw Deformity in Triploid Atlantic Salmon (Salmo salar L.)
PLOS ONE | DOI:10.1371/journal.pone.0168454 December 15, 2016 13 / 21
assembly, quality of the FASTQ files was assessed using CLC Genomics Workbench v4 (CLC
bio, Aarhus, Denmark), using default parameters. Based on the QC reports, FASTQ files were
trimmed using CLC with default parameters with the addition of trimming 10 nucleotides
from the 5’ of all reads.
Bioinformatics and statistics
De novo assembly of the trimmed reads was performed in CLC Genomics Workbench v4
using default parameters with the exception of minimum contig length elevated to 500.
Trimmed reads were mapped to the assembly in CLC Genomics Workbench v4 using default
parameters with the exception of similarity fraction elevated to 0.9. BAM files (resulting in
77.05 ± 0.23% mapped reads per library) were then imported into Partek Genomics Suite (Par-
tek Incorporated, St. Louis, MO, USA) for differential gene expression (DGE) analysis. All
BAM files are available at https://dx.doi.org/10.6084/m9.figshare.4229555.v1. In Partek GS,
categorical attributes were assigned to each duplicate in the LJD and Normal, followed by
DGE analysis without restricting paired-end compatibility. One-way ANOVA was performed
in Partek GS to compare reads per kilobase per million (RPKMs) with contrast between the
LJD and Normal samples. The same one-way ANOVA procedure was performed following
restricting RPKM 1 in at least one sample and defining the minimum as RPKM = 0.05. The
final list of transcripts used in the analysis was retrieved by selecting transcripts having at least
a 2 fold change between the LJD and Normal samples with an unadjusted significance level of
P< 0.05.
The prediction of the amino-acid sequences corresponding to the transcripts was per-
formed using the ORF-PREDICTOR website (http://proteomics.ysu.edu/tools/OrfPredictor.
html). CLC main workbench 7.5 (CLC Inc, Aarhus, Denmark) at default parameters was used
to perform a BLASTP (sequence comparisons and alignment) against the database of the
National Center for Biotechnology Information (NCBI) and annotate and predict the most
likely corresponding product (best hit) in Atlantic salmon. After the BLASTP, only matches
with E-value 1.00E-40 were selected for the analysis. Discrimination of the best hit obtained
for each sequence was performed based on the E-value 1.00E-40. In case the first best hit
resulted in an unannotated product the second was chosen (named ‘actual hit’). In order to
ascertain that the expression of the differentially expressed genes was not basal, only the subset
of transcripts where the sum of RPKM in all four samples was 5, were considered.
cDNA synthesis, probe and primer design for qPCR
Parallel to the transcriptome analysis, we tested in Normal and LJD samples from the experi-
mental sample set a group of previously known transcripts whose function was annotated to
be related to bone and cartilage physiology in vertebrates. The transcripts selected were: alka-
line phosphatase (alp), bone morphogenetic protein 4 (bmp4), collagen type I alpha 1 (col1a1),
collagen type II alpha 1 (col2a1), fibroblast growth factor 23 (fgf23), insulin like growth factor 1
(igf1),matrix metallopeptidase 13 (mmp13) and osteocalcin (ocn) (Table 3). Among the tran-
scripts found to be differentially expressed after transcriptome analysis, the following were
selected according to the quantitative values of differential expression, concurrently with their
previously known or possible relation to bone and cartilage physiology: fibrillin 2 (fbn2), galac-
tose-specific lectin (gal) and glycoprotein hormone beta 5 (gphb5) (Table 4). All the eleven tran-
scripts reported above were later tested in Normal and LJD samples from the industrial sample
set to compare gene expression patterns between the independent sample sets. Furthermore,
some of the transcripts (alp, col1a1, col2a1, mmp13 and ocn) were also tested in Normal and
LJD samples from the additional sample set (elevated rearing temperature) in order to
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investigate the possible effect of the temperature on differential expression (14˚C vs 18˚C). 18S
served as a housekeeping calibrator gene in both assays. Following RNA extraction and quanti-
fication, 1 μg of total RNA was reverse-transcribed into cDNA using Tetro cDNA synthesis kit
(Bioline, London, UK), according to manufacturer’s instructions. Probes for qPCR were
designed by the Universal ProbeLibrary System (Roche, http://www.roche-applied-science.
com) and primers for transcripts previously annotated were purchased from GeneWorks Pty
Ltd (Hindmarsh, SA, Australia) while primers for transcripts selected after transcriptome anal-
ysis were purchased from Sigma-Aldrich (Castle Hill, NSW, Australia).
Real-time qPCR assays
Real-time qPCR assays were performed in duplicates using FastStart Universal Probe Master
(ROX) (Roche, Australia) according to manufacturer’s protocol in a Rotor-Gene 6000 Real-
Time PCR Machine (Corbett Robotics Pty Ltd, Brisbane, Australia) with the following thermal
cycling conditions: 95˚C for 10 min, followed by 40 cycles of 95˚C for 15 sec and 60˚C for 60
sec. For each gene the control used was a duplicate no-template. Average cycle threshold for
each duplicate was calibrated relative to 18S and basal expression levels (which refers to the
lowest expressing tissue measured) and transformed to represent relative expression quantity
as 2-ΔΔCT. Nonparametric test for independent samples (Mann-Whitney U test) was used to
investigate significant differences between relative expression levels of each transcript between
traits (Normal and LJD) and different temperature treatments. All data analyses were
Table 3. Primers and probes used for real-time qPCR designed from previously known transcripts whose function was annotated to be related to
bone and cartilage physiology (abbreviations described in the text). * Sequence for fgf23 is available in S1 File.
Transcript Orientation GenBank accession number Tm Sequence (5’-3’) Probe cat.no.
(Roche)
alp Forward
Reverse
FJ195609.1 59
59
cagctgagcagacagagtggcaacaaaggggaacttgtcc 04689011001
bmp4 Forward
Reverse
NM_001139844.1 60
60
ggttgccgctaacactgacttggggtcttttcttagcgtct 04687582001
col1a1 Forward
Reverse
FJ195608.1 60
59
agcctggtgctaagggagagccttagctccggtgtttcc 04688619001
col2a1 Forward
Reverse
FJ195613.1 59
59
tcgacatgtctgccttcgtcagccctcatgtacctcaa 04693442001
fgf23 Forward
Reverse
Sequence from our sequencing
database*
59
60
ggatcagaagggtcaaccacaacacggtgccactggag 04685059001
igf1 Forward
Reverse
EF432852.2 60
59
ggcttttatttcagtaaaccaaccgtccacaataccacggtta 04688546001
mmp13 Forward
Reverse
NM_001140524.1 59
60
ccattccctcggtctcagaggtgctggggtttgtgtag 04684974001
Ocn Forward
Reverse
FJ172977.1 60
60
tgtgtgtgccactctattggatcttttctcactagcaggctttg 04689119001
18s Forward
Reverse
FJ710886.1 59
60
aggactccggttctattttgtgcggccgtccctcttaatc 04688546001
doi:10.1371/journal.pone.0168454.t003
Table 4. Primers and probes used for real-time qPCR from selected transcripts found differentially expressed after transcriptome analysis in the
experimental sample set (abbreviations described in the text). Sequences available in S1 File.
Transcript Orientation Tm Sequence (5’-3’) Probe cat.no.(Roche)
fbn2 Forward Reverse 59 60 cacgacagcgacacttgaaggctcacaactgtgacatgc 04687582001
gal Forward Reverse 59 59 ctttgaactgcagtgagaccactcatgactcccatgatgacc 04694449001
gphb5 Forward Reverse 60 59 Tgtagggagggtcaaggacagagggcttcacatcaccac 04685059001
doi:10.1371/journal.pone.0168454.t004
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performed using GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla,
CA, USA) with a significance level of P< 0.05. Results are represented as mean ± standard
error of the mean (SEM).
General Histology
The left halves of the lower jaws collected from the experimental sample set were used for all
histological analyses. Tissues were rinsed and decalcified for 72 h in a 10% EDTA solution
buffered with 0.1 M TRIS base, pH 7.0 as described in [84] and supplemented with Pro-
tectRNA™ RNase Inhibitor (Sigma-Aldrich, Castle Hill, NSW, Australia). After that, a protocol
modified from [85] was used. Briefly, tissues were dehydrated gradually through a series of
increasing alcohol concentrations and embedded in Paraplast1 Plus (McCormick Scientific
Leica™, North Ryde, NSW, Australia) according to conventional procedures. Serial sections of
7 μm were cut from the sagittal plane of the lower jaw, until reaching the area in which teeth,
bone and Meckel’s cartilage were visible, and placed onto Superfrost™ Ultra Plus Adhesion
Slides (Thermo Fisher Scientific, Scoresby, VIC, Australia). Duplicate and consecutive sections
were used for Hematoxylin and Eosin (H&E) staining and in-situ hybridization.
H&E staining
The slides were deparaffinized in xylene and rehydrated gradually through a series of decreas-
ing alcohol concentrations (100%, 90%, 70%, 50%). After rinsing in water the slides were
stained in hematoxylin for 4 min and rinsed again. Slides were placed for 30 sec in acidic alco-
hol (70% + 0.1% HCl), rinsed, stained in eosin for 3 min, rinsed again and gradually dehy-
drated through a series of increasing alcohol concentrations (50%, 70%, 90%, 100%), bathed in
xylene and finally mounted.
In-situ Hybridization
To design the primers for the in-situ hybridization probes, the sequences obtained from the
transcriptome analysis of gphb5 were blasted using Primer-BLAST (http://www.ncbi.nlm.nih.
gov/tools/primer-blast/) and primers (Sequence 5’-3’—Forward gtgtacatggggtccacgtt and
Reverse gagaagcctgtccttgaccc) purchased from Sigma-Aldrich (Castle Hill, NSW, Australia).
Digoxigenin-labeled oligonucleotides for antisense and sense probes were synthesized using
T7 RNA polymerase, and the probes were hydrolysed to reduce their length to approximately
200 bases, as described in the Digoxigenin Application Manual (Roche Applied Science, India-
napolis, IN). Slides with samples from the lower jaw were deparaffinised, rehydrated, rinsed in
diethyl pyrocarbonate (DEPC)-treated water and then washed in PBS for 6 min. Samples were
digested with 5 μg ml-1 of proteinase K (Roche Diagnostics GmbH) in PBS with Tween 20
(PBST) for 10 min at 37˚C and incubated in PBST containing 2 mg ml-1 of glycine for 5 min at
room temperature. Samples were rinsed again two times in PBST and fixed in 4% paraformal-
dehyde in PBS (10 mM phosphate buffer Na2HPO4, 150 mM NaCl, pH 7.4) for 4 min and
again washed PBS containing 0.1% DEPC for 20 min and in PBS until pre-hybridization at
room temperature. Pre-hybridization was performed at 48˚C for 2 h in pre-hybridization
buffer (50% 20X formamide, 10% saline sodium citrate, 40% dextran sulfate, tRNA 10 mg/ml,
heparin 50 mg/ml and 10 mg ml-1 of sheared and denatured salmon sperm DNA). Hybridiza-
tion was performed at 48˚C overnight with 0.2 μg ml-1 of antisense and sense probes in hybrid-
ization buffer (identical to pre-hybridization buffer). Samples were washed three times for 5
min in 4X wash (50% formamide, 30% DEPC-treated water, 20% 20X SSC—0.15 M sodium
chloride and 0.015 M sodium citrate—50 μl of Tween 20), three times for 5 min in 2X wash
(50% formamide, 40% DEPC-treated water, 10% 20X SSC, 50 μl of Tween 20) and three times
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for 5 min in 1X wash (50% formamide, 45% DEPC-treated water, 5% 20X SSC, 50 μl of Tween
20) at 48˚C. Samples were washed again three times for 5 min in 1X SSC with 0.1% Tween 20
and two times for 2 min in maleic acid buffer (MAB) (0.1 M maleic acid, 0.015 M NaCl, 0.1%
Tween 20, pH 7.5) at room temperature. Blocking was performed at room temperature for 2 h
with MAB block (2% BM block in MAB) and finally samples were incubated with Anti-Digox-
igenin-AP (Roche, Australia) at 4˚C overnight. Following incubation, samples were washed
four times for 5 min with MAB, two times for 5 min with 1X alkaline phosphatase buffer (AP)
(50% 1 M Tris, 40% DEPC-treated water, 10% 5 M NaCl, 0.01% Tween 20) and two times for
5 min 1X AP with 5% MgCl2 at room temperature. Final incubation was performed at 4˚C
overnight with 20 μl ml-1 of NBT/BCIP (Roche, Australia) in developmental buffer (5% polyvi-
nyl alcohol in 1X AP with 5% MgCl2). Slides were dehydrated in alcohol 70%, 100% and
cleared with xylene before mounting with DPX (Sigma-Aldrich). Sections were observed
under a Nikon ECLIPSE E600 light microscope and photographed.cg
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